Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

Braxia Scientific sees COVID-19 suicide research published in prestigious medical journal

Braxia Scientific sees COVID-19 suicide research published in prestigious medical journal

Braxia Scientific CEO Dr. Roger McIntyre joined Steve Darling from Proactive to share the news that research led by McIntyre has been published in the Journal of the Royal Society of Medicine. McIntyre telling Proactive, this research is entitled "Suicide reduction in Canada during the COVID-19 pandemic. It was initiated to evaluate the impact of federal, public health and social support programs on national suicide rates in Canada, which were put in place to mitigate the abrupt changes to social and financial provisions brought on by the COVID-19 pandemic. The results included the overall suicide mortality rate decreased in Canada from 10.82 deaths per 100,000 in March 2019 to February 2020 to 7.34 per 100,000.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK